Related Experiment Video
Updated: May 5, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 18, 2011
The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Abstract:
In this issue, Hughes-Davies et al. describe a novel gene product, EMSY, which suppresses the transactivational activity of BRCA2. EMSY is located within an amplicon in sporadic breast and ovarian cancers, suggesting that its overexpression may mimic the effects of BRCA2 inactivation. The implications for BRCA2 function are discussed.
Insights
A new gene product, EMSY, hinders BRCA2
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- BRCA2 is a crucial tumor suppressor gene.
- Its inactivation is linked to hereditary breast and ovarian cancers.
- The function of BRCA2 in DNA repair and genome stability is well-established.
Discussion:
- EMSY, a novel gene product, inhibits BRCA2's transactivational activity.
- EMSY is amplified in sporadic breast and ovarian cancers.
- EMSY overexpression may replicate BRCA2 inactivation effects.
Key Insights:
- EMSY acts as a suppressor of BRCA2 transactivation.
- EMSY amplification in cancers suggests a role in tumorigenesis.
- This finding provides new insights into BRCA2's tumor-suppressive mechanisms.
Outlook:
- Further research into EMSY's role in cancer development.
- Exploring therapeutic strategies targeting EMSY in BRCA2-related cancers.
- Investigating the interplay between EMSY and BRCA2 in DNA repair pathways.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Related Concept Videos
Mitogens and the Cell Cycle
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...